Investing

Today's Market Winners and Losers

Future-market-tradingThe stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the S&P 500 down 0.39%. Today’s sole winner is a pharmaceutical company with a kidney drug that passed a trial, and today’s sole loser announced that its yearly profit will fall short of prior estimates.

This is today’s market winner and loser.

Biggest Winner

Shares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) are up 41.40% to $4.85 on trading volume of 10.7 million shares. A kidney disease drug the company is trying to get on the market has passed a late-stage trial. The 52-week high is $5.19.

Biggest Loser

Shares of Jos. A Bank Clothiers Inc. (NASDAQ: JOSB) are down 16.25% to $38.75 on trading volume of 1.7 million shares. The company announced that 2012 profit will fall 20% compared to the prior year because of warmer-than-usual weather and U.S. political unease. Before Monday, the 52-week low was  $39.54.

Follow Samuel on Twitter: SWeigley

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.